(Total Views: 284)
Posted On: 12/16/2021 8:06:06 AM
Post# of 63

$MTNB News Article - Matinas BioPharma Announces Unanimous DSMB Approval to Progress into Fourth and Final Cohort of Patients in the EnACT Trial of MAT2203 (Oral Amphotericin
for the Treatment of Cryptococcal Meningitis https://marketwirenews.com/news-releases/mati...17771.html



My Twitter: WhyteStocks